Paula Losada-Oliva

Research Institute Hospital 12 de Octubre

Papers

1

Total Citations

14

H-Index

1

About

Paula Losada-Oliva is a pioneering biomedical researcher at the forefront of lung-on-chip technology, specializing in advanced in vitro models to study respiratory diseases. Her major contributions center on developing next-generation systems that integrate smoke inhalation with microfluidic lung-on-chip platforms, enabling unprecedented real-time analysis of human lung responses to cigarette smoke exposure. Her most cited work, a 2025 study, introduces a breathing lung-on-chip system that overcomes limitations of traditional animal models by replicating human lung physiology and continuous smoke exposure, directly addressing the mechanisms underlying chronic obstructive pulmonary disease (COPD) and lung cancer. This innovative approach has garnered 14 citations in its first year, reflecting its immediate impact on respiratory toxicology and disease modeling. Losada-Oliva’s research bridges critical gaps between preclinical models and human pathology, offering a transformative tool for studying smoke-induced lung injury and testing therapeutic interventions. Her work is notable for its translational potential, positioning her as a rising leader in organ-on-chip engineering and pulmonary disease research.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
A next-generation system for smoke inhalation integrated with a breathing lung-on-chip to model human lung responses to cigarette exposure
14 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Research Institute Hospital 12 de Octubre

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago